Usman Mahmood

Goulburn Valley Health Australia

Usman Mahmood is a Consultant Nephrologist at Darling Downs Hospital and Health Service, Australia. He underwent post-graduate training in various public hospitals across three different states and has a range of experience in various areas of Nephrology and General Medicine including both Metropolitan and Indigenous Healthcare. His special interests include: Chronic Kidney Disease, Fluid and Electrolyte Disorders, Renal Vasculitides, Hemodialysis, General Medical Conditions, Hypertension management, Lupus Nephritis, Glomerulonephritis, and Kidney Transplantation. He has authored a number of book chapters and has published in various peer-review journals. Dr. Mahmood also enjoys teaching junior medical staff including medical students. He can speak four languages and is well equipped to look after patients from sub-continent background.

1books edited

1chapters authored

Latest work with IntechOpen by Usman Mahmood

This book provides readers with all the tools needed to handle interesting clinical challenges in the field of fluid and electrolyte disorders. It aims to offer an up-to-date clinical text for medical residents, fellows, practicing physicians, and nephrologists in a simple and easy-to-understand format. It provides the right balance between basic science and practical clinical guidance. It discusses the current evidence regarding the physiology, basic fundamentals, clinical presentation, and management of these disorders and will help clinicians to handle these disorders effectively. And all chapters have been extensively revised and bound to include the latest developments in the field.

Go to the book

Fluid and Electrolyte Disorders

Edited by Usman Mahmood

Chapters authored

Peritoneal Dialysis Solutions

By Usman Mahmood, Yeoungjee Cho and David W. Johnson

Conventional peritoneal dialysis (PD) solutions are characterized by several undesirable characteristics, including acidic pH (5.2–5.5), high glucose concentrations (13.6–42.5 g/L), hyperosmolarity (360–511 mOsm/kg) and relatively high concentrations of glucose degradation products (GDPs). These characteristics have been shown to result in adverse clinical outcomes, including acute peritoneal membrane toxicity (manifested as inflow pain), chronic peritoneal toxicity (including membrane failure, ultrafiltration failure, peritonitis and encapsulating peritoneal sclerosis) and adverse systemic sequelae (including hyperglycaemia, dyslipidaemia, metabolic syndrome, cardiovascular disease and residual renal function decline). Consequently, there has been a great interest in manufacturing newer solutions with more ‘biocompatible’ features to mitigate these adverse effects. This has led to the development of neutral‐pH, low or ultralow GDP solutions, glucose‐sparing PD solutions (icodextrin and amino acid solutions), solutions using alternative osmotic agents (such as hyperbranched polyglycerol) and low‐sodium PD solutions. The aim of this chapter is to provide an up‐to‐date comprehensive review of all types of PD solutions that are currently available, including their impact on patient‐level outcomes.

Part of the book: Some Special Problems in Peritoneal Dialysis

Usman Mahmood

Latest work with IntechOpen by Usman Mahmood

Fluid and Electrolyte Disorders

Chapters authored

Related collaborators

Dominik Alscher

Martin Kimmel

David Johnson

Desmond Y. H. Yap

Olga Balafa

Obinna Obinwa

Yeoungjee Cho

Daniel Kitterer

Terence Yip

Joerg Latus